Should pharmacotherapy targeting lipoprotein(a) be further expanded for patients with diabetes?
Eur Heart J Cardiovasc Pharmacother
.
2024 May 2:pvae033.
doi: 10.1093/ehjcvp/pvae033.
Online ahead of print.
Authors
Yihong Sun
1
,
Koji Hasegawa
2
,
Heinz Drexel
3
Affiliations
1
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100020, China.
2
Division of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto, 612-8555, Japan.
3
Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Vorarlberg, 6800 Austria.
PMID:
38697932
DOI:
10.1093/ehjcvp/pvae033
No abstract available